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EXECUTIVE SUMMARY
Female genital mutilation/cutting (FGM/C) continues to be a threat to women’s and girls’ health
and human rights globally. A sizeable body of evidence has developed over the past three
decades on the direct health impacts of FGM/C. However, the evidence has been spread out and
detached in diverse research, interventional, and training materials, making it cumbersome for
quick reference when responding to women and girls exposed to the health effects of FGM/C.
The Africa Coordinating Centre for the Abandonment of Female Genital Mutilation/Cutting
(ACCAF), with support from the Population Council, sought to synthesize the evidence on the
health impacts of FGM/C, identify recommended interventions, and compile and analyse the
existing reference materials.
The goal of the review was to inform the development of a comprehensive set of training
guidelines and materials for frontline health care providers so they can manage the care of
women and girls who have undergone FGM/C, prevent the practice at the community level, and
accelerate abandonment of FGM/C practices. An analysis of existing systematic reviews, metaanalyses, and published studies on health impacts associated with FGM/C and their specific
interventions was conducted. A content analysis of 44 reference materials related to FGM/C was
conducted using an updated data abstraction form that included 17 review criteria. Descriptive
statistics were applied to the generated data to understand the components of the analysed
documents. A review and validation of the outcomes and interventions were carried out by
medical experts on the ACCAF team.
The health impacts associated with FGM/C that require interventions have been broadly
categorised into: immediate, genito-urinary, gynecological, obstetric, sexual and psycho-social
consequences. An analysis of existing training and research reference materials on FGM/C
management showed major strength in epidemiology, but scored marginally on physical,
gynecological, and obstetric complications. In addition, the reference materials scored poorly on
the sexual and psycho-social impacts of FGM/C. Curative and preventive interventional
approaches are recommended in the review for the various health consequences. Specifically,
capacity building for health care providers to respond to women exposed to FGM/C in both health
care facility and community settings should be prioritized. In addition, strengthening the health
care systems by anchoring FGM/C interventions to existing programs and socio-community
structures, especially in high prevalence areas, and by establishing supervisory mechanisms,
protocols, documentation, and referral systems where expert care is lacking, among other
interventions, will greatly help the response to the needs of cut women and girls while preventing
new FGM/C cases.
This analysis underscores the health impacts associated with FGM/C and compelling reasons for
their interventions. Overall, the recommended interventions were informed by recommended
best practices based on study reports, experts, and the strength of the available evidence.
Women’s health is a human rights issue and women’s empowerment cannot be separated from
issues related to women’s health. Therefore, a comprehensive, user-friendly training guide is
required. Moving forward, Evidence to End FGM/C: Research to Help Girls and Women Thrive
plans to collaboratively review existing curricula and related materials for health professionals
before these much-needed training materials and guidelines for health care providers can be
drafted; and to conduct new research to deepen understanding on all the health impacts of
FGM/C and their interventions.
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1.0 BACKGROUND
1.1 Context
Female genital mutilation/cutting (FGM/C) is a culturally entrenched global practice that not only
is considered an evident human rights violation but also has resultant health and social
repercussions on girls and women. It has been implicated in serious health consequences,
significant morbidity, health burden, and poor health indicators [1, 2]. A sizeable body of
evidence has been developed over the past three decades on the direct health impacts of
FGM/C. Systematic reviews by the Norwegian Knowledge Centre for the Health Services provide
a useful summary of these impacts, organized into obstetric, gynecological, and immediate
health consequences depending on the type of FGM/C [3]. There are four documented types of
FGM/C: clitoridectomy (type 1), the partial or total removal of the clitoris and prepuce; excision
(type II), the partial or total removal of the clitoris and the labia minora; infibulations (type III), the
narrowing of the vaginal orifice through creation of a covering seal by cutting and placing
together the inner and/or outer labia with or without the removal of the clitoris; and others (type
IV), including non-therapeutic harmful procedures to the female genitalia such as pricking,
piercing, incising, scraping, and cauterization [2]. Researchers have alluded to the fact that
FGM/C has also been associated with social, sexual, psychological, and mental consequences
for women and girls.
To enable health practitioners to address the consequences associated with FGM/C, WHO,
various ministries of health, organizations, and experts have presented information in the form of
training and intervention materials. Currently, however, there is no single comprehensive
reference material and practitioners are required to consult various materials when faced with an
FGM/C challenge. This can be inefficient and wasteful in terms of time for both clients and
providers, and in some cases may result in serious complications or the loss of life. Therefore, a
comprehensive package of interventions, skills support, and training materials on health impacts
associated with FGM/C would be most useful to health practitioners. Such materials would
support the provision of appropriate, efficient, and effective gynecological, obstetric, medical,
and related treatment services, including preventive strategies.
This synthesis has been spearheaded by the ACCAF team, with support from the Population
Council and in consultation with recognized professional experts in the field of FGM/C, including
WHO and FIGO.

1.2 Rationale
This review synthesis describes the health consequences of FGM/C, identifies recommended
interventions, and assesses existing interventional and training materials with an aim toward
informing a formal review of curricula and the development of user-friendly materials for
mitigating the health consequences of FGM/C. The review is composed of three components: the
health impacts associated with FGM/C, the medical and socio-community interventions
recommended for the consequences, and analyses of FGM/C reference materials for inculcating
knowledge, management skills, and prevention of the practice by health practitioners. The
components of this review document are interrelated and are intended to synergize each other
seamlessly.
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2.0 APPROACH AND METHODS
2.1 Objectives
The ultimate goals of this review are to support recommendations for the development of
appropriate, user-friendly training materials and resources for use in medical training colleges for
trainee health providers; and to inform the in-service and/or continuous medical education for
health care providers already working in high-prevalence FGM/C areas, for appropriate corrective
as well as preventive interventions in the various settings.
To achieve this goal, the following specific objectives were addressed:
i.

Review existing systematic reviews, meta-analyses, and published studies to identify the
strongest evidence concerning FGM/C-related health outcomes for which interventions
could be recommended.

ii. Identify medical and socio-community interventions that have been recommended for the
health consequences associated with FGM/C and its prevention.
iii. Compile, review, and identify strengths and weaknesses of existing reference materials
and propose improvements that would enhance pre-service training for frontline health
care providers and that could be adapted for in-service training courses.

2.2 Desk review
The review of the literature was conducted using the terms “female genital mutilation,” “female
genital cutting,” or “female circumcision” combined with medical subject heading (MeSH) terms
“obstetrics,” “gynecologic,” psychologic,” and “women’s health” and keywords “health impacts,”
“health effects,” “health outcomes,” “health consequences,” “interventions,” “training manual,”
and “training guidelines.” Databases, including PubMed/MEDLINE, were searched applying the
following parameters: year of publication between 1985 and 2015; human; and in the English
language. The titles and abstracts of all articles identified through the literature search were
scanned for relevance. Documents were selected for full review if they specifically mentioned
FGM/C and reported data on health impacts, interventions, prevention, and training materials
related to FGM/C. Human observational studies were reviewed, including cross-sectional, casecontrol, prospective, and comparative studies; meta-analyses conducted on existing studies data;
and cohort or population-based studies that used quantitative methodology. The respondents
included women, girls, and health professionals, such as obstetricians, gynecologists, nurses,
midwives, and researchers. The review included health impacts associated with FGM/C,
recommended prevention and interventions to mitigate the health effects, and materials that
should be included in training as a requirement for health care providers to care for women and
girls affected by FGM/C and for prevention of the practice. Publications were excluded if they
used qualitative study designs because of the non-randomized nature of sampling techniques
and the pitfalls thereof; were not in English and could not be translated by default language
translation software; or were more than 30 years old.
Quality measures for considering the systematic reviews and research reports included: sample
description (details included women and girls with all types of FGM/C, nationality, and age of
respondents); sampling method (description of site/setting and sampling procedure); credibility
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of researcher/author (professional midwife, nurse, obstetrician, gynecologist, surgeon, or
researcher); and whether or not the systematic reviews were reviewed by content experts.
Additionally, the reviewed papers offered citation sources for health outcomes, their
interventions, and prevention and training guidelines for health professionals. These citations
were subjected to PubMed/MEDLINE databases for retrieval and scrutinized to meet the
aforementioned criteria. To supplement this process, other literature and training materials that
were not available online were obtained from ACCAF, Population Council, and subject matter
experts. Data were extracted and then any inconsistencies were resolved by checking full-text
versions of the documents, counterchecking against the latest literature, and discussing with
field experts.

2.3 Data and analysis
After reviewing relevant documents and
identifying the FGM/C health consequences,
the reference materials were compiled and
scored, and recommended interventions were
outlined.
The
compilation
involved
systematically assessing the evidence within
the existing reference materials and
published studies. The components of FGM/C
in each individual piece of evidence were
assessed using a standard data abstraction
form that included 17 review criteria (Box 1).
The criteria were developed based on a
combination of different categories as
provided in three guideline documents [4, 5,
6] and formed the basis for analysing what
should be included in comprehensive, userfriendly training materials.
Each individual reference material was
assessed based on the presence of key
components of FGM/C (Box 1). Their
strengths and weaknesses were further
determined based on details and depth of
content material elaboration.

Box 1: Seventeen review criteria developed
for assessing FGM/C reference materials
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17

Criteria: Key components of FGM/C
Present=✔
Absent=O
Background and description of FGM/C
Complications of FGM/C
FGM/C and human rights
FGM/C management during pregnancy, labor,
delivery, and postpartum period
Management of girls and women with gynecological
complications
Management of girls and women with sexual
complications
Management of girls and women with
psychological/mental complications
Counseling
Medicalization
Professional ethics and legal implications of FGM/C
Community involvement in prevention of FGM/C
Community health education and advocacy
FGM/C and family planning
Referral procedure
Research
Training
Monitoring and evaluation

A total of 44 reference materials were compiled, analysed, and categorised into three groups:
interventional (73%; n=32), training materials (11%; n=5), and research reports (16%; n=7),
respectively. The analyses of the materials involved ascertaining whether or not they captured
the specific FGM/C components in the 17 review criteria. The analyses of the materials based
on the criteria outlined in Box 1 yielded the following key insights as presented in Tables 1 and
2.

3

Table 1. Percentage score of reference material based on 17 review criteria
Percentage category (%)
75 and above
50-74
25-49
0-24
Highest
Lowest

Score out of 17

Frequency n (%)

13-17
9-12
4-8
0-3
15 (88%)
1 (6%)

5 (10)
6 (13)
16 (33)
21(44)
3 (7)
5 (11)

Table 2. The overall scores on specific FGM/C components for the reviewed reference materials
S/No
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17

Components of FGM/C
Background and description of FGM/C
Complications of FGM/C
FGM/C and human rights
FGM/C management during pregnancy, labour, delivery, and postpartum
period
Management of girls and women with gynecological complications
Management of girls and women with sexual complications
Management of girls and women with psychological/mental complications
Counseling
Medicalisation
Professional ethics and legal implications of FGM/C
Community involvement in prevention of FGM/C
Community health education and advocacy
FGM/C and family planning
Referral procedure
Research
Training
Monitoring and evaluation

Scores, n (%)
42 (96)
41 (93)
29 (66)
26 (59)
24 (55)
19 (43)
18 (41)
22 (50)
26 (59)
32 (73)
25 (57)
25 (57)
11 (25)
16 (36)
23 (52)
14 (32)
11(25)

Of the 44 reference materials analysed using the 17 review criteria for FGM/C components, the
highest score was 15 (6.8%, n=3) while the lowest was 1 (11.4%, n=5) (Table 1). Only 10.4%
(n=5) scored 75% and above, while 12.5% (n=6) scored 50 to 74% on the 17-point criteria. More
than 75% (n=20) of the analysed reference materials contained less than 50% of the key FGM/C
components. The highest (88.2%) score was 15, achieved by 6.8% (n=3), while the lowest (5.9%)
score was 1, attained by 11.4% (n=5) of the reference materials, respectively. Only 25% (n=11)
of the reference materials met 50% and above of the criteria. On the other hand, 40.9% (n=18)
of the materials scored below 25% of the criteria.

3.0 REVIEW FINDINGS
3.1 Synthesis of evidence: Health impacts
This section outlines the health impacts attributable to FGM/C as collected from the systematic
reviews, meta-analyses, and published studies conducted in the past three decades. The review
identified 5 categories of health impacts attributable to FGM/C: immediate, genito-urinary,
obstetric, sexual, and psycho-social complications. The health impacts described in the sections
below, based on available scientific evidence on FGM/C accumulated over the last three
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decades, warrant interventions by health care providers in health facilities as well as in
community settings.
3.1.1 Immediate (acute) complications
The cutting of women’s and girls’ clitoris and labia is usually done with crude unsterile
instruments and without anesthesia, by traditional practitioners who have little knowledge of
female anatomy [7]. The cutting results in immediate harm. Bleeding (haemorrhage) occurs due
to laceration or severing of branches of the pudendal or clitoral arteries, which have high blood
pressure, causing a strong flow of blood during and shortly after the cutting process. Other
immediate complications include shock, genital tissue swelling, fever, infections, problems with
urination (acute urinary retention, hesitancy), and delayed wound healing, as corroborated by
observational studies involving large samples of women and girls of various ages who had
undergone various types of FGM/C [3] and by study reports [8, 9]. Evidence also shows that girls
suffer more than one immediate complication, and in some cases deaths have been attributed
directly to FGM/C [10-14]. Death can result from severe bleeding, pain and trauma, severe and
overwhelming infection, or a combination of these complications. The immediate harms vary with
the type of FGM/C, with the greatest risk seen among type III, relative to types I and II [15] (Table
3).
The evidence on the magnitude of immediate complications associated with FGM/C varied
across the reviewed studies. This variation may have been due to under-reporting of the
complications or to the timing of post-procedure observations. Some studies have reported very
high rates of girls who have undergone FGM/C but experienced no bleeding [15, 16]. Such
disparities may be the result of methodological differences in data collection, with clinical
assessment likely to be more objective and accurate, while self-reporting may result in gross
under-reporting. This reasoning is supported by the fact that many women underwent FGM/C as
infants or children and they may not remember any immediate adverse effects. Furthermore,
women may not link complications arising during childbirth or later in life to the genital cutting
they underwent as children. Additionally, FGM/C-related complications may be considered as
normal and natural to women, especially among populations where FGM/C is nearly universal,
due to social norms [17].
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Table 3. Immediate (acute) outcomes attributed to FGM/C
Outcome
Bleeding
Pain
Shock
Genital
tissue
swelling
Fever
Infections
Urination
problems
Delayed
wound
healing
Death

Reasons
Laceration to pudendal and/or clitoral
arteries, which have high flow and
pressure
Injuries to cut tissues and nerves, swelling
and pressure, no anesthesia
Blood loss (haemorrhagic shock), severe
pain and trauma (neurogenic shock), which
can be fatal
Trauma and injured tissues of urethra,
vagina, perineum, and rectum
Inflammation, trauma, infection
Unsterile procedure, skin destruction (e.g.,
tetanus, hepatitis, HIV)
Swelling, inflammation around the wound,
fear of pain of passing urine on the raw
wound, or injury to the urethra
Failure of wound to heal due to infection,
irritation from urine or rubbing when
walking, or an underlying condition, such
as anemia or malnutrition
Severe bleeding, pain, and trauma, or
severe and overwhelming infection, or a
combination of the above

Number of
studies/type
56/
Observational
Representative

Sample
size (n)
133,515

(S)/(NS)1

References

S

Berg et al.
2014;
Almroth et al.
2005
El Dareer
1983; Trew
2013; Migiro
2014; Asuen
1977; Badejo
1983; Osifo &
Evbuomwan
2009

3.1.2 Late (chronic) genito-urinary problems
Female genital cutting is associated with chronic problems affecting the genital and/or urinary
systems of women and girls. This has been corroborated by several comparative studies involving
large numbers of women and girls [3, 18, 19]. The specific genito-urinary problems commonly
reported include: genital tissue damage, vaginal discharge, itching, urological complications, and
infections [3]. In light of this evidence, interventions for these complications should be
developed. Other genito-urinary outcomes such as scarring, keloids, abscesses, fistulae,
damaged tissue (perineum, anal sphincter), disfigurement, vaginal obstruction, and cysts are
rarely encountered in the research reports, possibly because of lack of rigorous research and
documentation [3]. This may be due to methodological differences in data collection and the fact
that most studies do not disaggregate chronic genital urinary problems data against the type of
cutting, which may affect the interpretation of the data [3] (Table 4). Additionally, some
outcomes, such as HIV, STDs, and infertility, are rarely encountered in the literature and not
reported.

1

S=significant; NS=not significant
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Table 4. Late (chronic) genito-urinary outcomes attributed to FGM/C
Outcome

Rationale for the
outcome

Study type

Studies

Sample
size (n)

(S) /
(NS)2

References

Vaginal
discharge

Infections

Crosssectional

4

3,657

S

Nwanjei & Otiono 2003;
Okonofu et al. 2002; Elnashar
& Abdelhady 2007

Vaginal
itching

Infections, trauma,
reaction due to
discharge

Crosssectional

4

3,657

S

Morrone et al. 2002; Okonofu
et al. 2002; Elnashar &
Abdelhady 2007

Painful
urination

Damage to the
urethral opening or
scarring of the
meatus

Comparative

6

3,611

S

Morison et al. 2001; Okonofu
et al. 2002; Elnashar &
Abdelhady 2007; De Silva
1989

Menstrual
problems3

Due to partial or total
occlusion of the
vaginal opening

Crosssectional

5

6,564

S

INSEED 2005; El Defrawi et al.
2001; Morrone et al. 2002;
Nwajei & Al Otieono 2003

Chronic
genito-urinary
infections

Ascending urinary
tract infections

Comparative

10

28,940

S

INSEED 2005; El Defrawi et al.
2001; Fillo & Leone 2007

Reproductive
tract
infections

Occlusion of the
vagina and urethra
causing stasis and
climbing of the
infections

2

2,412

Genital
infections

Trauma, entry of
Crossinfectious organisms, sectional
inflammation due to
discharge
Prospective

2

2,412

S

Jones et al. 1999; Brewer et al.
2007

Urinary tract
Infections

Occlusion of the
urethra

Meta-analyses 5

9,414

S

INSEED 2005; El Defrawi et al.
2001; Browning et al. 2010;
Fillo & Leone 2007

Meta-analyses 5

9,414

S

Nwajei & Otiono 2003

Bacterial
vaginosis
Genital tissue
damage

HIV

STDs

Infertility

Trauma, entry of
infectious organisms,
reaction due to
discharge
Trauma due to
FGM/C, inflammation
due to discharge,
infections
Small vaginal
opening, cuts and
tears, sharing of
cutting instruments
Trauma, entry of
infectious organisms,
inflammation due to
discharge, poor
hygiene due to pain
Pelvic infections,
damage to
reproductive organs,
painful intercourse

Crosssectional

S

Jones et al. 1999; Brewer et al.
2007

Prospective

Crosssectional

4

3,657

NS

1
10*

12,912

NS
NS

1
10*

12,912

NS
NS

2
10*

36,473

NS

Case-control
Crosssectional
Case-control
Crosssectional
Case-control
Crosssectional

Morison et al. 2001; Nwajei &
Otiono 2003; Okonofu et al.
2002; Elnashar & Abdelhady
2007
Klouman et al. 2005;
Maslovskaya et al. 2009;
Yount & Abraham 2007; Balk
2000
Nwajei & Otiono 2003;
Klouman et al. 2007;
Maslovskaya et al. 2009;
Yount & Abraham 2007; Balk
2000
El Defrawi et al. 2001;
Browning et al. 2010; Nwajei &
Al Otiono 2003; Yount &
Abraham 2007; Inhorn & Buss
1993; Jackson et al. 2005;
Larsen & Okonofua 2002; Berg
& Underland 2013

* The higher number represents case-control studies while the lower number represents cross-sectional studies.
2
3

S=significant; NS=not significant.
Dysmenorrhea, difficulty in menstruation, irregular menses, and difficulty in passing menstrual blood.
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In Table 4, the complications from the late (chronic) genito-urinary outcomes attributed to FGM/C
were gleaned from systematic reviews and study reports. Corrective and preventive interventions
for both common and rare outcomes are recommended at health facilities and in community
settings.
3.1.3 Obstetric complications
The obstetric complications, notably prolonged labour, tears and lacerations, caesarean sections,
episiotomies, instrumental deliveries, postpartum haemorrhages (PPHs), and difficult labour
associated with FGM/C were documented from numerous comparative studies involving large
samples of women and girls [3, 35, 36] (Table 5).
Table 5. Obstetric outcomes attributed to FGM/C
Outcome

Type of study

Prolonged
labour

Comparative

Number of
studies
5
1

Sample size (n)

(S) / (NS) 4

References

715,079
(6,324)

S

15

738,672
(17,961)

S

Berg et al. 2014; Berg &
Underland 2013; Johnson
et al. 2005; Chibber et al.
2011; Meirik et al. 2006
Berg et al. 2014; Berg &
Underland 2013; Johnson
et al. 2005; Chibber et al.
2011; Meirik et al. 2006;
Wuest et al. 2009
Berg et al. 2014; Johnson
et al. 2005; Chibber et al.
2011; Meirik et al. 2006;
Wuest et al. 2009
Berg et al. 2014; Fillo &
Leone 2007; Vangen et al.
2002; Johnson et al. 2005;
Chibber et al. 2011; Berg &
Denison 2012
Berg et al. 2014; Johnson
et al. 2005; Chibber et al.
2011

Prospective
Tears and
lacerations

Comparative
Prospective

Caesarean
section

Prospective

15

2.74M
(41,306)

S

Episiotomy

Retrospective

11

35,467
(23,869)

S

9

2.34M
(12,557)

S

Cross-section
Prospective

10

746,667
(27,626)

S

Berg et al. 2014; Johnson
et al. 2005; Chibber et al.
2011

Prospective

7

11,659
(3,252)

S

Berg et al. 2014; Berg et al.
2014; Johnson et al. 2005;
Chibber et al. 2011; Wuest
et al. 2009

Prospective
Instrumental
delivery

Registry study
Prospective

Postpartum
haemorrhage
(PPH)
Difficult
labour

Cross section
Comparative

In Table 5, the obstetric outcomes attributed to FGM/C are shown. These complications are
associated with substantial suffering by women and girls. In the reference materials, it is
recommended that corrective and preventive interventions be developed and/or strengthened at
the health facility and community levels to deal with these consequences.

4

S=significant; NS=not significant.
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3.1.4 Sexual functioning complications
This synthesis revealed that FGM/C is associated with sexual complications. Women who had
undergone cutting were more likely to report painful intercourse, no sexual desire, less sexual
satisfaction, and less experience of orgasm compared to their uncut counterparts. Other sexual
outcomes reported include women not initiating sex and lack of knowledge of the most sexually
sensitive part of their bodies [42] (Table 6).
Table 6. Sexual functioning outcomes attributed to FGM/C
Outcome

Number of
studies

Sample
size (n)

(S)
/(NS) 5

6
Painful intercourse

Satisfaction
Sexual desire
Experienced orgasm
Initiated sex

5
2
5
2

3657*

Reference

S

Berg et al. 2014; El Defrawi et al. 2001; Morrone
et al. 2002; Nwajei & Otiono 2003; Elnashar &
Abdelhady 2007; De Silva 1989; Adinma 1997

S

Morrone et al. 2002; Berg & Denison 2012;
Adinma 1997; Alsibiani & Rouzi 2010

S

Morrone et al. 2002; Adinma 1997; Thabet &
Thabet 2003; Shandall 1967

S

Adinma 1997; Thabet & Thabet 2003; Shandall
1967; Megafu 1983; Rushwan 2000

NS

Morrone et al. 2002; Elnashar & Abdelhady
2007; Adinma 1997

* Cross-sectional studies

Table 6 outlines the sexual functioning outcomes attributed to FGM/C. The corrective and
preventive interventions for sexual complications should include strategies for identification,
management, monitoring, and prevention.

3.1.5 Psycho-social complications
FGM/C or its delayed complications may trigger the onset of one or a combination of the
following complications: acute anxieties, depression, neuroses, psychoses, and post-traumatic
stress disorder. The physical complications arising from FGM/C may also interfere with women’s
and girls’ social lives because of ill health. For example, incontinence may interfere with their full
participation in social activities and lead to isolation. Difficult penetration and infertility affect
sexual life and may precipitate divorce [48]. The findings under this outcome were inconclusive
because of the small number of studies that were reviewed, as well as the low quality of the
methodological approach of the studies.

5

S=significant; NS=not significant
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3.2 Synthesis of evidence: Curative and preventive interventions recommended
for health impacts of FGM/C
The review revealed various complications associated with FGM/C. This section outlines the
interventions as recommended in these materials for alleviating and preventing FGM/Cassociated complications, both in health facilities and in socio-community settings. The section
also forms the basis for reviewing existing interventions and/or training materials, curriculum,
and capacity building for health professionals, with a view toward strengthening training
materials and resources to provide better care for women and girls exposed to FGM/C and to
prevent the practice.
3.2.1 Training of health care professionals
Public health services play a critical role in the prevention and mitigation of FGM/C and its
harmful effects on women’s health. Thus the training of health care providers will be a key
response. The materials recommend that training of health care professionals include
comprehensive and technical knowledge about FGM/C to aid in promoting abandonment of
FGM/C practices and to enable clinical management of those impacted by FGM/C. For example:
 Frontline health care providers should be aware of the impacts, including immediate,
physical, sexual, psychological, and social, associated with FGM/C and should consider
the practice when assessing, managing, counseling, and/or referring women and girls for
reproductive, pregnancy, and delivery health services.
 As a result of the immediate (acute) nature of the complications caused by FGM/C,
women and girls present to health facilities in very desperate conditions, requiring quick
and effective interventions. It is recommended that health care professionals (doctors,
nurses, and midwives) should be well-trained in the diagnosis and management of
FGM/C-associated complications in patients who are admitted to or visit outpatient
clinics immediately following genital cutting.
 To deal with late (chronic) complications such as
dermoid cysts and keloids, it is recommended that
health professionals be trained to recognize,
advise, counsel, and treat patients with these
complications, as well as to perform curative
procedures such as fistula repair and deinfibulation [49-54].
 It is recommended that hospitals in FGM/Cendemic areas have their health care providers
trained on caring for FGM/C-exposed women.
Since infibulated women run the highest risk
during labour, doctors, nurses, and midwives
should be trained to develop expertise in the
assessment and management of women with
infibulations, including competencies to carry out
de-infibulation and management after deinfibulation (Box 2) [55, 56].

Box 2: Example: Skill sets for deinfibulation
Recommendation: Women must undergo
de-infibulation before conception,
especially if difficult surgery is anticipated.
 Doctors, nurses, and midwives are
trained to develop expertise in the
assessment and management of
women with infibulations and following
de-infibulation.
 Clients are counseled that deinfibulation can restore an opening to
the vaginal canal to allow for normal
urination, menstrual flow, and sexual
intercourse.
 Psychosexual counseling should be
provided before and after deinfibulation.
 De-infibulation may be carried out in
any suitable outpatient room equipped
for minor procedures or in an operating
theatre.
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3.2.2 Provision of counseling and psycho-social support
There is increasing evidence that “FGM and its associated health risks are psychological
stressors that can lead to a variety of negative psychological and psychiatric outcomes” [57].
Recommendations for health care providers include the following:


Provide counseling and advice to clients based on anticipated complications associated
with FGM/C, including encouraging women to deliver in a hospital with qualified
assistance.



Recognize the underlying psychological complications of FGM/C and refer women and
girls for appropriate psychological/counseling care.



Utilize cognitive behavioural therapy, which has been found to be effective in preventing
and treating post-traumatic stress disorder.



Establish institutional, peer, and community-based counseling groups.



Recognize the sexual problems that women face as a result of FGM/C and routinely
provide counseling for women with such complaints.



Initiate referral mechanisms, including linking clients with qualified sexologists.



Provide counseling and psycho-social support interventions for clients who access health
facilities, as well as for those in community settings. The role of sexologists and sexual
therapy should be pursued.

3.2.3 Addressing social conventions and norms and creating awareness
Health care providers play a key role in raising people’s awareness, bringing attention to the
health impacts of FGM/C and encouraging behaviour change in the social conventions and
norms that underpin the practices of FGM/C. The review illuminates the need to:


Enhance capacity of health care providers to raise awareness of the health impacts
associated with FGM/C and encourage them in their roles as advocates, role models,
counselors, and caretakers to contribute to the mitigation and abandonment of the
practice [58-60].



Anchor FGM/C preventive messages to existing reproductive health programs in health
facilities, as well as in community settings, which will go a long way towards prevention
and management of these complications.



Familiarize all maternity healthcare providers with the nature and higher rates of
complications related to FGM/C.



Encourage women and girls to seek medical care if they have complications, because
such complications may become intensified or even cause death, and also encourage
them to avoid traditional remedies because the use of herbs can lead to severe bleeding
or introduction of infections [48].



Support health care providers in establishing community approaches to dealing with
consequences of FGM/C (e.g., community psycho-social support, debriefings, and
establishment of networks).
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Sensitize communities to the fact that some of the reproductive and medical
complications women and girls present with at health service points are associated with
FGM/C and that they can be traced to childhood trauma such as FGM/C. Raising
awareness in this manner would enhance identification of the complications and lead to
better-health seeking behaviour and promotion of preventive strategies.



Involve local administration, law enforcement, prosecutors, and the judiciary in raising
awareness in communities about anti-FGM/C laws and the consequences of breaking
these laws, and increasing knowledge about prosecutions and penalties.



Lay the foundation for norm change by educating communities and professionals that
FGM/C is a violation of human rights and raising community awareness about the global
instruments against FGM/C, notably the United Nation General Assembly and Human
Rights Council of 2012 and 2014 resolutions [42, 58, 61-63].



Undertake concerted educational interventions involving all stakeholders on the facts
about FGM/C, thereby counteracting myths that are used to perpetuate the practice,
such as “FGM/C is supported by religion,” and “the practice makes woman more fertile,”
among others.



Dissociate FGM/C from religion by involving religious leaders and the community through
capacity building [59].



Partner with communities to develop abandonment strategies for FGM/C, including
participation in documentation, anonymous reporting, monitoring, and tracking of the
FGM/C practice.



Encourage traditional excisors to abandon the practice and empower them to obtain
income from other means.



Empower women and girls through economic opportunities, education for the girl child,
and dissociation of FGM/C from dowries.



Establish anti-FGM/C campaigns among community structures and formal institutions
like schools and churches to accelerate abandonment.



Involve both men and women in the fight against FGM/C, helping them to associate the
practice with its health consequences and thereby accelerating its abandonment.

3.2.4 Strengthening health systems
Health systems should be strengthened to respond to the health impacts of FGM/C on women
and girls in the following ways:


Develop intervention protocols, given the nature and seriousness of FGM/C
complications. Cascade protocols to all health care facilities, especially in FGM/Cprevalent areas. Establish referral and supervisory mechanisms to address those
complications where expert care is lacking.



Integrate FGM/C strategies into existing health care delivery, including reproductive
health, family planning, and youth-friendly services, among others, to leverage and
maximize cost effectiveness.



Support capacity building for facilities and health care providers, including supervision.

12



Review curricula in order to benefit health care trainees in training colleges.



Provide facilities with equipment and supplies for addressing FGM/C complications.



Equip health facilities to be able to deliver health and sexual education to women with
FGM/C-related complaints.



Lobby for the strengthening of the health care system to respond to FGM/C challenges,
including the establishment of efficient referral systems and the financing and buying of
supplies.



Establish supervisory and referral mechanisms to track and report cases, including
information on how cases were resolved.



Involve professional associations and regulatory bodies to create awareness among
professional members of complications of FGM/C, including medicalised cutting; illegality
of FGM/C; and penalties for medicalisation, including de-registration of violators [64, 65].

3.2.5 Documentation and research
Developing, and facilitating access to, information resources and databanks will be vital to
designing appropriate responses to specific contexts to address the health impacts of FGM/C.
From the evidence gathered, the following interventions have been recommended.


Research and analyses of the impact on babies and infants who have undergone FGM/C
are highly recommended.



Research into psychological consequences associated with FGM/C needs to be
prioritized. Too little research has been performed to date to establish the true
association between FGM/C and psychological disorders.



More research is needed that uses rigorous methodological design to further document
the sexual complications of FGM/C.



A large study with a more rigorous methodology is needed to elicit the psycho-social
consequences of FGM/C and hence inform programming. Multidisciplinary and
multifactorial causes should also be considered since FGM/C is often one of the factors
resulting in mental consequences, alongside others such as migration and other past
violent events. Therefore, consideration of the mental consequences of FGM/C should be
given priority for research, as should interventions through counseling and
psychotherapy.



Additionally, further research should be conducted on the rare outcomes associated with
FGM/C. HIV, STDs, and infertility are rarely encountered in the literature and are not
reported. Therefore, further research is recommended to establish whether the findings
may be replicated. Because these medical complications, which are of public health
importance, are infrequently reported and therefore lack statistical significance, it is
recommended that high-level methodological research on these complications be
conducted.



Furthermore, more rigorous methodological (case controlled, randomized, and
longitudinal) and large-scale studies should be conducted in the area of sexual function.

13

3.3 Improvements to enhance pre-service training for frontline health care
providers
The analysis revealed various types of gaps in the reference materials. The materials varied in
the depth and coverage of the details of the FGM/C components (Tables 1 and 2). Whereas the
materials were strong on background information, they were typically weak on coverage of
interventions. Of the 44 analysed materials, most (96%; n=42) had detailed background and
introduction information. The materials scored marginally on obstetric (59%; n=26), gynecologic
(55%; n=24), counseling (50%; n=22), medicalisation (59%; n=26), and community involvement
(57%; n=25) themes. The analysis further revealed glaring deficits in the depth of content on the
skills enhancement and training materials on FGM/C. The materials rated poorly on sexual (43%;
n=19), psychological/mental (41%; n=18), family planning (25%; n=11), referral procedure (36%;
n=16), and monitoring and evaluation (25%; n=11) components.
The analysis demonstrated that the background information, including the epidemiology of
FGM/C, was well covered in almost all the reference materials. There are numerous studies on
the “what,” “why,” and “who” questions about FGM/C in an endeavor to understand the practice
[4]. The components of FGM/C that are critical for interventions and protocols in caring for
women and girls with health complications, such as obstetric, gynecologic, counseling,
medicalisation, and research components, were marginally addressed. Furthermore, other
components such as sexual, psychological, mental health, family planning, referral procedure,
monitoring, and evaluation components, were poorly covered. This shortcoming could be
attributed to lack of scientific evidence as a result of poor or no research in these critical areas.
The components may be suffering neglect due to an underestimation of their magnitude, as a
result of inadequate evidence and funding. Whereas maternal and child issues have received
considerable attention and funding, the psychological and sexual impacts of FGM/C have been
neglected [3, 66]. These shortcomings in the reference materials may have serious implications
for the management of women and girls living with FGM/C and for the fight against the practice
in health facility and community settings. There is greater need, therefore, to develop a
comprehensive, user-friendly training guide and provide skills enhancement support and training
materials for FGM/C frontline health care professionals working in the curative sector, as well as
for those in the preventive sectors, to accelerate abandonment of the practice.
The analyses further revealed glaring gaps in both curative and preventive interventions
protocols. This is possibly due to the lack of evidence and assessment of interventions for most
of the identified health outcomes [3]. Several interventions are recommended in order to
enhance training, programming, and messaging for medical care providers such as: establishing
referral systems where expert care is lacking, strengthening health care systems to respond to
FGM/C challenges, and building the capacity of frontline health care professionals to enable
them to offer curative and preventive services in FGM/C-prevalent areas (Table 7). The findings
also highlight the importance of anchoring preventive interventions for FGM/C to existing
community health care systems and socio-community structures, especially in high-prevalence
areas, in order to address challenges faced by cut girls and women while preventing new FGM/C
cases. The review findings therefore recommend the development of comprehensive, userfriendly training guides and resource materials that are suitable for professionals who work in the
hospital setting (curative) as well as community (preventive) sectors of health. Furthermore,
more studies need to be conducted to fill the gaps identified in the health impacts of FGM/C to
address the methodological pitfalls affecting some of the thematic areas, such as the sexual and
psychological domains [3].
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Table 7: Summary of review findings: Key messages
Recommended Curative and Preventive Interventions
Health Impacts

Immediate
(acute)
complications

Late (chronic)
genito-urinary
problems

Obstetric
complications













Health assessment for early accurate diagnosis of complications
Fluid replacement therapy including blood transfusion
Anti-pain therapy
Immunization against tetanus
Antibiotic therapy for infections
Surgical management including infection control and prevention
Health education (awareness) linking FGM/C to complications
Advocacy towards seeking medical assistance and avoidance of traditional herbs
Documentation, monitoring, and evaluation, including integration of FGM/C cases into health statistics reporting systems
Establishment of efficient referral mechanisms
Engagement of all stakeholders to raise awareness among communities about anti-FGM/C laws, implications of breaking these
laws, and human right violations; clarify myths about the practice; and dissociate the practice from religion











Health assessment for early accurate diagnosis
De-infibulation
Surgical/wound care management including plastic surgery
Establishment of efficient and referral mechanisms
Antibiotic therapy for infections
Infection control and prevention
Health education
Fistula identification, management, and care
Documentation, monitoring, and evaluation







Health assessment for accurate diagnosis including types of FGM/C and re-infibulation cases
Psychological and counseling support
De-infibulation
Surgical/wound care management
Establishment of efficient and referral mechanisms for complicated dermoid cysts, keloids, and scarring at the time of
pregnancy
Antibiotic therapy for urinary infections
Infection control and prevention
Health education, including on hospital delivery, association between FGM/C and complications, avoiding use of herbs
Blood balance maintenance through bleeding control, fluid replacement, blood transfusion, hematinics
Documentation, monitoring, and evaluation







Gaps found in training
materials, interventions,
messaging, and research
on health impacts

 Interventions and
protocols for managing
women with health
complications such as
obstetric and gynecologic
complications,
counseling needs,
medicalisation, and
research, were
marginally addressed in
the materials.
 Sexual, psychological,
mental health, family
planning, referral
procedure, monitoring,
and evaluation were
poorly covered.
 Documentation,
information, and access
to research were absent.
 Monitoring and
evaluation of healthrelated outcomes were
rarely documented.
 Rigorous methodological
and large-scale studies
were lacking especially in
the area of sexual
function.
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Sexual
functioning
complications

Psycho-social
complications








Health assessment for accurate diagnosis of sexual complications
Psychosexual and counseling support
Health education including sexual education linking FGM/C with sexual dysfunction
Establishment of efficient and effective referral mechanisms including linkages with sexologists
Implementation of high-quality methodological research
Documentation, monitoring, and evaluation











Health assessment for accurate diagnosis of psycho-social complications
Psycho-social and counseling support
Establishment of efficient and effective referral mechanisms for psychiatric/psychological/counseling and complicated cases
Health education linking FGM/C with psycho-social problems
Cognitive behavioral therapy to prevent and manage post-traumatic stress disorder
Routine screening and management programs for psycho-social complications
Establishment of institutional, peer, and community support groups
Implementation of high-quality methodological research on psycho-social problems
Documentation, monitoring, and evaluation

Recommended improvements to enhance pre-service training for frontline health care providers
 Initiate health care professionals’ training through engagement with regulatory bodies to allow for curricula review, then develop interventional/training materials for pre/inservice and reference materials on FGM/C. This will enable the providers to manage for FGM/C-exposed women, raise awareness to prevent new cutting, and empower them
to resist medicalisation, including re-infibulation.
 Strengthen the health care system to respond to women exposed to FGM/C and to prevent girls from being cut, through the following approaches:
 Stock health facilities with necessary supplies and equipment.
 Train health care providers on FGM/C services through continuous professional development.
 Develop, cascade, display, and update FGM/C management protocols.
 Integrate FGM/C into existing health care programs (e.g., antenatal care, youth friendly, and family planning services).
 Promote task shifting for nurses, midwives, medical assistants, and medical officers. In hard to reach areas where doctors and specialists are not available, nurses and
midwives should be allowed to perform lifesaving interventions such as de-infibulation, which may not be within their professional jurisdictions, without risk of litigation. This
shift is possible through lobbying of stakeholders, especially regulatory bodies, to review their requirements and mandates for specific professionals.
 Lobby for inclusion of FGM/C statistics in the health statistics reporting system to promote tracking, monitoring, and evaluation that will influence planning, decisionmaking,
and funding at the county and national government levels and for donors.
 Establish facilitating supervisory mechanisms to enable professionals to provide management and ensure that the health care system is well capacitated to respond to FGM/C
challenges.
 Establish a databank for complications across the spectrum associated with FGM/C with hospitals
 Support health systems and specialists to manage the above-mentioned databank and to track the outcomes of interventions to manage complications (for monitoring,
evaluation, and review purposes).
 Support de-medicalisation, including no re-infibulation for women.
 Increase cultural competence on language and sensitivity of FGM/C as a highly cultural issue.
 Research the sexual, psychological, and social complications to inform policy, practice, and programming.
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CONCLUSION
The health impacts of FGM/C have received different levels of attention, both in terms of
interventions and evidence. Based on these recommendations, there is a need to communicate
this evidence base to a range of stakeholders, taking into consideration that key messages are
carefully crafted to ensure appropriate interpretation and guidance for action. This approach is
especially important when using this evidence for medical and behaviour change interventions,
given the sometimes less than successful responses to health messaging observed over the past
decade. Information on the health consequences would be of most use in both hospital facilities
and community settings [56, 65] to help in providing appropriate gynecological and obstetric
services and medical treatment to women and girls immediately following cutting. This objective
can be achieved through health care provider training and skills empowerment, health system
strengthening, documentation and research on FGM/C issues. The health care system
strengthening should therefore include establishment of an efficient and effective referral system
where expertise may be lacking in order to support corrective and preventive interventions for
FGM/C in all settings.
Building the capacity of frontline health care professionals to offer curative and preventive
services in FGM/C-prevalent areas in both hospital and community settings may be enhanced
through lobbying for curricula review and development of training manuals and guidelines.
Anchoring preventive interventions for FGM/C to existing health care programs and sociocommunity structures, especially in high-prevalence areas, will be a promising approach to
address challenges faced by cut girls and women while preventing new cutting. Furthermore,
large-scale, high-quality methodological studies are recommended for specific neglected
complications (sexual, psychological, and mental) associated with FGM/C to inform future
preventive and corrective programs. Additionally, curative and preventive strategies for protecting
girls and women from cutting need to be initiated and escalated at the socio-community level.
Raising awareness of the relationship between FGM/C and health problems may increase health
seeking behaviour and reporting, aiding early identification and management before
complications set in.
The health impacts resulting from FGM/C place a burden on health systems, however, little is
known of the costs, especially of the obstetric complications associated with FGM/C [67]. While
this synthesis focused on interventions that may facilitate effective responses to women and girls
exposed to the practice and promote its prevention, it is critical to also consider the cost
effectiveness of the interventions for planning and programming purposes.
Furthermore, the recommended interventions for preventing and addressing FGM/C in this
synthesis not only seek to address FGM/C as a practice rooted in gender-based discrimination
and social norms but also other forms of violence against women and girls [68, 69].
Women’s health is a human rights issue and women’s empowerment cannot be separated from
issues related to women’s health [70]. Moving forward, Evidence to End FGM/C: Research to
Help Girls and Women Thrive plans to collaborate with policymakers, development partners,
professional regulatory bodies, trainers, and other key stakeholders to review the curricula and
related materials for health professionals before the much-needed training materials and
guidelines for health care providers can be drafted; and to conduct new research to deepen
understanding of all the health impacts of FGM/C and their interventions.
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